• vcard
D 314.622.6663
F 314.754.9946
  • Education
    • J.D., magna cum laude, University of Wisconsin Law School, 2005
    • B.A., cum laude, Carleton College, 1999

Margaret Hillman focuses her practice on transactional and regulatory matters affecting health care providers. She works with clients on a wide array of transactions, with an emphasis on mergers, acquisitions, and divestitures.

Margaret’s understanding of her clients’ businesses enables her to provide valuable strategic advice during all steps of a transaction. She also routinely handles licensure, certification, and reimbursement matters, both in the course of company operations and in connection with acquisitions. Margaret works with her clients to achieve their business objectives while still maintaining compliance with complex health care laws and regulations.

Clients for whom she provides services include home and alternate site infusion providers, home health agencies, durable and home medical equipment providers, physician groups, and private equity funds.

Before attending law school, Margaret worked in the press office at the U.S. Department of Health and Human Services, where she was able to get an insider’s view of the way health care policy is made.

 

  • Worked on all aspects of BioScrip’s $70 million acquisition of home infusion provider HomeChoice Partners, including due diligence, negotiation, and drafting of the purchase agreement and ancillary documents and licensure change of ownership. Continue to work on integration following the closing of the transaction.
  • Advised Mediq on corporate and regulatory aspects of its $38 million acquisition of urological and other home medical supply provider A-Med Healthcare. Transaction significantly expanded Mediq’s subsidiary, Byram Healthcare’s, position in the California home care market.
  • Represented AEA Investors in regulatory matters connected with its acquisition of National Rehab Equipment, Inc., in July 2007; National Rehab’s add-on acquisition of All South Services, Inc. in May 2010; and AEA’s sale of National Rehab to McKesson Corporation in September 2012. During AEA's ownership period, provided regulatory advice regarding operational matters to position National Rehab for ultimate sale.
  • Assisted radiology group in negotiating a services agreement to provide exclusive radiology services at two affiliated hospitals. Worked with the group and hospital to anticipate future needs as the field of radiology continues to change.
  • Represented a nonprofit operator of skilled nursing facility in connection with its discussions with its lender following loan default. After negotiation, transferred the facility to the lender with commitments to maintain the Jewish ambiance of the facility.
  • Represented Thompson Street Capital Partners in its acquisition of DCL Medical Laboratories in October 2007, providing an array of regulatory and corporate advice to DCL during Thompson Street’s ownership and then advised Thompson Street on its sale of DCL to LabCorp in June 2010.
  • Advised on regulatory aspects of BioScrip’s acquisition of Critical Homecare Solutions, including managing significant change of ownership filing process and regulatory due diligence.
  • Advised Option Care on regulatory matters in connection with its sale to Walgreens Co. for total consideration of approximately $850 million.